Headquarters- Mumbai, Maharashtra.
Area served- India.
Key people- Dharmil Sheth and Dr Dhaval Shah.
Net Worth- $1.8 Billion (June 2021).
Number of employees- 1000 plus.
Pharmeasy is an Indian health tech startup that was founded in 2015 by Dharmil Sheth and Dhaval Shah and company owned by the API holding Pvt Ltd. Its offering services like teleconsulting, diagnostics test sample collection and online medicine delivery. The company maintained 6000 plus digital consulting clinics and 90000 plus Partner retailers networks across the country. Pharmeasy is headquartered in Mumbai Maharashtra.
Pharmeasy was launched in 2015 by the co-founder Dharmil Sheth, Dhaval Shah. The company main focus is on easy access to pharmacy and diagnostics tests. It started with the sole application of making healthcare accessible and affordable to every Indian. Pharmeasy is India’s leading and most trusted online healthcare aggregator in the country. It helped the patients to connect with local pharmacy stores and diagnostics centres to fulfil their medical needs.
Pharmeasy was India’s first Epharmcy startup to joined the unicorn start-up club in April 2021. It ha acquired the rival start-up Medlife online medicine delivery service in May 2021, after eight-month it’s received Competition Commission of India (CCI) approval.
In June 2021, the company also acquired a 66.1 per cent stake in the listed diagnostic chain Thyocare Company for Rs 4546 Cr.
2016- Pharmeasy has raised $ 5 million dollars through series A round of funding from Bessemer venture partners.
2017- The company also raised $ 2 million dollars from Bessemer venture partners through a Series B round of funding.
2018- Pharmeasy has raised $ 50 million dollars through a Series C round of funding from Bessemer venture partners.
2019- In Nov, Pharmeasy raised $ 220 million dollars through a Series D round of funding from investors like Eight roads venture, Temasek Holding, Orios venture partner, Light rock, KB Financial Group, Fundamentum.
2021- In April 2021, The company has raised % 350 million dollars fund at a valuation of $ 1 billion, through its series E round of funding from its investors Prosus, Temasek, Eight roads venture, TPG growth, Think investment, Lightrock.
In July 2021, Pharmeasy has raised $ 500 million dollars at a valuation of $ 4 billion through the series F round of funding from its investors such as Tiger Global Management, TPG growth, Orios venture partner, Temasek, B Capital growth, Kotak private equity, Prosus venture.
Products and services
Pharmeasy is India’s leading and most trusted online healthcare and medicine delivery aggregator in the country. The company provides online medicine, healthcare products and Diagnostics tests. Its health care products portfolio featured different categories like Covid essential, Personal care, Skincare, Nutrition and Fitness supplement, Ayurvedic care, Baby & Mom’s care, Ortho care, Device etc.
Pharmeasy delivered medicine in 1000 plus cities in India with covering 22000 plus Pincode. They offered diagnostic test services across Mumbai including Thane, Kalyan, Dombovalli, Navi Mumbai and other metro cities like Delhi, Noida, Lucknow, Ghaziabad, Faridabad, Gurgaon, Vadodara, Surat, Chennai, Hyderabad, Kolkata, Bangalore and Jaipur.
Pharmeasy online payment Partner comprises Google pay, Phone Pe, Amazon Pay, Paytm, MobiKwik, Ola money, Airtel Bank, and card payment partners MasterCard, Visa, Rupay.
Partner with Pharmeasy or Seller
Pharmeasy provides a partnership in business and grows your business through the online presence of pharmacy stores. You need to fulfil the Person details and Your pharmacy store details. The company will help to grow your business and widen the reach to customers.
Simple Four-Step Process to Get Listed on Pharmeasy.
- Submit your pharmacy store details.
- Provide license details and GSTIN details.
- Sign the Services agreement.
- Training and Go live.
You can simply apply from the pharmeasy Website and App and click on the ‘Partner with us’ portal.
Pharmeasy plans to raise $ 1 billion in funds through its public listing of fresh issue shares at a valuation of $ 9 billion dollars. Currently, 80 % of the Stake of the Pharmeasy parent’s company API holding is held by Investors such as TPG growth, Temasek, CDPQ, Eight roads, Think investment, Prosus venture.
UX & Design Head